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Abstract 
Background: Shunt obstruction in the treatment of hydrocephalus is poorly understood, is multi-factorial, and in 
many cases is modeled ineffectively. Several mechanisms may be responsible, one of which involves shunt infiltration 
by reactive cells from the brain parenchyma. This has not been modeled in culture and cannot be consistently exam-
ined in vivo without a large sample size.
Methods: We have developed and tested a three-dimensional in vitro model of astrocyte migration and proliferation 
around clinical grade ventricular catheters and into catheter holes that mimics the development of cellular outgrowth 
from the parenchyma that may contribute to shunt obstruction.
Results: Cell attachment and growth was observed on shunt catheters for as long as 80 days with at least 77 % 
viability until 51 days. The model can be used to study cellular attachment to ventricular catheters under both static 
and pulsatile flow conditions, which better mimic physiological cerebrospinal fluid dynamics and shunt system flow 
rates (0.25 mL/min, 100 pulses/min). Pulsatile flow through the ventricular catheter decreased cell attachment/growth 
by 63 % after 18 h. Under both conditions it was possible to observe cells accumulating around and in shunt catheter 
holes.
Conclusions: Alone or in combination with previously-published culture models of shunt obstruction, this model 
serves as a relevant test bed to analyze mechanisms of shunt failure and to test catheter modifications that will pre-
vent cell attachment and growth.
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Background
Hydrocephalus, an imbalance between cerebrospinal 
fluid (CSF) production and absorption, is a chronic dis-
order causing abnormal enlargement of the cerebral 
ventricles and ventriculomegaly. Since 1955, the stand-
ard treatment for hydrocephalus has been the surgical 
placement of shunts to drain CSF [1]. However, pediat-
ric shunts have one of the highest failure rates among 
neurological devices; 40  % of shunts fail within 2  years 
of implantation [2]. Hospitalizations for hydrocepha-
lus have reached 70,000 per year in the USA. Nearly all 
patients (98 %) who have hydrocephalus will experience 
shunt failure in their lifetime and most will undergo mul-
tiple shunt failures necessitating surgical revision [3]. The 
societal cost of shunt failure is significant, accounting for 
the bulk of more than $1 billion annual cost of hydro-
cephalus care in the USA, not to mention the patient 
morbidity and mortality associated with shunt dysfunc-
tion [4].
Approximately 70  % of shunt failures in the pediat-
ric population in the United States are caused by tis-
sue obstructing the proximal catheter in the ventricles, 
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population, obstruction dominates in the valve or distal 
catheter; the mechanisms behind this mismatch are not 
well understood. Previous studies have reported a vari-
ety of cell types and tissues present on obstructed ven-
tricular catheters comprising connective tissue, choroid 
plexus, glia-dense tissue masses, ependyma, and patho-
logical cells/tissues including necrotic cellular debris, 
foreign body giant cells, granulomatous cells, and acti-
vated microglia/macrophages and astrocytes [10]. Recent 
evidence suggests that astrocytes and microglia are the 
dominant cell types found directly bound to shunt ven-
tricular catheters [11, 12]. Obstructed shunt valves have 
similar cells bound to them, including glial cells, mac-
rophages/giant cells, and lymphomonocytic cells [11]. 
While the mechanisms causing ventricular catheter 
shunt obstruction and down-stream shunt valve obstruc-
tion are likely multi-faceted, inflammatory cells certainly 
play a major role in shunt obstruction in pediatric and 
adult patients. Perhaps mechanisms including single cell 
attachment, attachment of migrating and/or proliferating 
cells suspended in CSF, and/or attachment of activated 
glia from the brain parenchyma contribute to inflam-
matory-derived shunt obstruction. [11, 13]. An acti-
vated response of astrocytes and microglia is likely to be 
involved through repair processes stimulated bycatheter 
insertion and continued catheter presence (i.e. a “foreign-
body” response).
Because obstruction of the shunt system is a multi-
modal problem, high intrinsic variability in clinical and 
in  vivo studies require large numbers of observations, 
making these time-consuming and cost-prohibitive. In 
vitro modeling provides opportunities for more precise 
control of test variables, more rapid throughput, and 
more consistency of cell growth, but typically lacks the 
complexity found in the brain (for example, three-dimen-
sional (3D) ventricular and brain components with fluid 
flow). Novel in  vitro modeling can, in this way, provide 
insight into the mechanisms of inflammatory cell attach-
ment leading to shunt catheter obstruction. In a previ-
ous study, an effective in vitro system was developed to 
understand how single cells suspended in CSF adhere 
to catheters and contribute to obstruction [14]. In this 
study, we describe and characterize a 3D in vitro model 
that mimics shunt failures that occur secondary to cells 
from the brain parenchyma migrating along the cath-
eter and attaching to the CSF-intake holes, ultimately 
resulting in obstruction. Our objective was to construct 
a model for studying shunt catheter hole obstruction by 
reactive glia from brain parenchyma, one likely mecha-
nism of obstruction. This obstruction could result from 
either a change in catheter position within the ventricu-
lar system, or migration of cells down the catheter into 
the catheter holes [10]. In this model, cells from a scaffold 
molded around a clinical ventricular catheter, attach to 
the catheter in the scaffold, migrate along the external 
wall and, subsequently attach to and accumulate at shunt 
catheter holes. By using short- and long- chambers where 
CSF-intake holes are partially or totally exposed to the 
CSF, the system models migration of activated astrocytes 
and microglia out of the brain onto the shunt extend-
ing into the ventricle when the catheter is sub-optimally 
placed, or when placed in its intended location. This 
3D hydrocephalus bioreactor provides opportunities 
to make observations and measurements of cell growth 
over time with or without flow through the catheter, and 
provides an efficient test-bed to study modifications to 
shunt design or surface modifications to improve shunt 
performance.
Methods
Astrocyte cell isolation and maintenance
Procedures were approved by the Institutional Animal 
Care and Use Committee of Seattle Children’s Research 
Institute in accordance with the National Institutes of 
Health Guide for Care and Use of Laboratory Animals. 
Cortical hemispheres were removed from 3-day old rat 
pups after deep anesthesia was achieved using inhaled 
isofluorane. Tissue was cut into 1-mm3 pieces and sus-
pended in calcium-free Hanks balanced salt solution 
(Ca2+-HBSS, Invitrogen, Carlsbad, CA, USA). Astrocytes 
were cultured from these cortical hemispheres using 
previously published techniques [14]. Briefly, following 
dissection and mincing, the Ca2+-HBSS was removed 
and replaced by dissociation medium containing 0.25 % 
trypsin-1X EDTA and incubated for 45  min at 37  °C 
with 5 % CO2 in a 50-mL centrifuge tube. Fresh culture 
media was then added to quench the trypsin-activity 
and the tube centrifuged for 3 min at 1300 rpm to collect 
cells and tissue fragments (primary pellet). The resulting 
supernatant was collected, transferred into a new centri-
fuge tube, and centrifuged again to recover any cells that 
were not collected in the primary pellet. The primary 
pellet was cycled through a second dissociation and col-
lection process to maximum cell recovery. The primary 
pellet and the supernatant pellets were then combined, 
re-suspended, counted, and plated onto T-175 flasks 
(Invitrogen) at a density of 100,000 cells/mL, or approxi-
mately 1,000,000 cells/flask. Cultures were incubated 
at 37  °C with 5  % CO2. Complete culture medium con-
sisted of DMEM (Dulbecco’s Modified Eagle Medium) 
supplemented with 4.5  g/L d-glucose, 584  mg/L l-glu-
tamine, 110 mg/L sodium pyruvate (Invitrogen), 5 % fetal 
bovine serum (Invitrogen), 2  % penicillin–streptomycin 
(Invitrogen), and 0.001  % gentamicin (Sigma, St. Louis, 
MO, USA). When cells in primary culture reached 80 % 
confluence, cells not adherent to the culture flask were 
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removed and the adherent astrocytes were dissociated 
from the flask surface using 0.25  % trypsin-1X EDTA. 
After collecting the cells by centrifugation and re-suspen-
sion in complete medium, cells were passaged re-plated, 
loaded into scaffolds, or were frozen using Fisher’s Cry-
oMed Controlled-Rate Freezer (Thermo Fisher Scientific, 
Waltham, MA, USA) and stored in liquid N2. All cells 
used in these studies were replated no more than three 
times. Astrocyte cultures were fed three times/week.
Alginate scaffold construction
Alginate preparation
Peptide-modified alginate was used to construct a 3D 
scaffold around shunt ventricular catheters. These scaf-
folds can support cell attachment and growth [15–18]. 
Alginate is a natural polysaccharide cross-linked in the 
presence of Ca2+ without the addition of cytotoxic agents 
[17, 18]. Gel construction followed previously described 
methods [16, 18, 19]. A 1  % (w/v) sodium alginate 
(Sigma) solution in 0.3  M NaCl and 0.1  M 2-(N-mor-
pholino)ethanesulfonic acid hydrate (MES buffer) was 
initially functionalized with an RGD (arginine-glycine-
aspartic acid) peptide (GGGGRGDY) to improve cell 
attachment and viability [17, 18, 20]. For standard car-
bodiimide crosslinking chemistry, the following rea-
gents were added (in order) and incubated for 20  h at 
room temperature: 8.22  g/L sulfo-N-hydroxysulfosuc-
cinimide, 16.44  g/L 1-ethyl-3-[3-dimethylaminopropyl]
carbodiimide hydrochloride, 0.3  g/L RGD peptide, and 
10  g/L sodium alginate. The reaction was quenched by 
the addition of 13  g/L hydroxyl amine. The functional-
ized alginate was then dialyzed using a 3500 molecular 
weight cutoff snakeskin dialysis membrane (Sigma). The 
starting dialysis solution contained 7.5 g NaCl/L Milli-Q 
dIH2O. The NaCl content was gradually reduced by 
1.25  g/L every 8  h until dilution resulted in removal of 
all NaCl. After dialysis, a 30-min charcoal filtration treat-
ment was performed. The sample was then lyophilized at 
2000 × 10−3 mBar at −50 °C for 5 days. Prior to scaffold 
formation, a 5 % stock of functionalized alginate was pre-
pared in Ca2+-HBSS.
Chamber preparation
Chambers were assembled using an open polycarbonate 
base with an inlet and outlet port, a glass coverslip bot-
tom secured with silicone glue, and a loosely fitted poly-
carbonate top (Fig. 1). Assembled units, shunt catheters, 
and polycarbonate molds were sterilized with ethylene 
oxide gas (130  min at 51–54°, 8 PSI). To promote algi-
nate attachment to the chamber surfaces, chambers were 
treated with poly-l-lysine (PLL; 0.01 %) for 2 h at 37° and 
then washed in a bath of Milli-Q dIH20 for 5  min. The 
proximal portion of a clinical ventricular catheter was 
mounted in the chamber. The PLL coating was confirmed 
using water contact angle measurements on a subset of 
chambers. To build the alginate scaffold, a polycarbon-
ate mold (referred to as a “dam”) was positioned around 
a 32-hole (four rows of eight holes), barium impregnated, 
standard ventricular poly(dimethyl)siloxane (PDMS, 
silicone) shunt catheter (Medtronic, Goleta, CA, USA) 
using 4  % (w/v) low-melt agarose solution (Sigma) in 
sterile Milli-Q dIH2O to seal the spaces between the dam, 
catheter, and chamber (Fig. 2a, b).
Hydrogel components and chemistry
Alginate hydrogels/scaffolds were constructed by mix-
ing a sterile stock solution of 6 % (w/v) calcium carbon-
ate (Sigma), HBSS containing Ca2+, d-(+)-gluconic acid 
Fig. 1 Three-dimensional hydrogel scaffold to model shunt obstruction by brain parenchyma. Representations of short-chambered (a, c) and long-
chambered (b, d) perfusion systems. a, b Illustrations of cross-sections through the x,z plane provide details of the relative positions of the alginate 
scaffolds (blue profiles) and catheters. c, d Photographs of chambers provide views looking down on completed chambers. Short-chambered 
systems were first used with placement of the alginate scaffold over the four distal ventricular catheter CSF intake holes (a, c). Long-chambered 
systems were designed to enable alginate scaffolds to be placed in a more proximal position permitting all of the intake holes to be exposed to the 
perfusion system “ventricular” space (b, d). In a subset of experiments, media was pumped into the chamber, flowing to the outside of the catheter 
and through the catheter holes, then flowing through the inside of the catheter and out of the chamber and catheter (see flow dependent attach-
ment and growth subsection)
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delta-lactone (GDL), and RGD prepared as a 5  % (w/v) 
stock. The final alginate concentration was 1.5  % (w/v) 
using a 0.54 Ca:COOH molar ratio following previously 
published methods [16]. To make the scaffold, the 6  % 
CaCO3 solution was vortexed to create a “slurry”, where 
the CaCO3 was evenly distributed through the solution. 
Thirty-four microliters of CaCO3 was pipetted into a 
150 mg alginate aliquot and mixed, followed by the addi-
tion of 286  µL of Ca2+-HBSS. Working quickly, 30 µL 
of 214  mg/mL GDL was added to the alginate/calcium/
HBSS mixture and stirred. The total mixture was then 
pipetted into the space between the dam the chamber 
and incubated in a cell culture incubator (37 °C and 5 % 
CO2) for 90 min to enable crosslinking (Fig. 2c, d). Fol-
lowing incubation and cell loading (Fig.  2d–e), the aga-
rose and dam were carefully removed (Fig. 2f ).
Loading scaffold with cells
Astrocytes were harvested from 80 % confluent cultures 
as described above, counted using a phase hemocy-
tometer to determine the viable cell count, and re-sus-
pended in 50 µL culture media. Cells were injected into 
the center of the gel using two 25-μL aliquots to yield 
7.5  ×  106 cells/scaffold (total scaffold volume 500  μL, 
Fig. 2e). After a 5 min absorption period, complete cul-
ture media was added to the chamber to cover the scaf-
fold, and the chamber was returned to the incubator for 
continuous culture. The culture medium was replaced 
three times per week.
Design of 3D cortical cell model
Sterilized chambers containing the ventricular cath-
eters were built as either “short” or “long” units (Fig. 1) 
allowing for different positions of the dam relative to 
the catheter holes (see chamber preparation). The short-
chambered system (4-cm chamber length, 3.1-cm cath-
eter length) was designed so that the alginate scaffold 
would cover half of the 32 catheter holes (Fig. 1a, c). The 
short-chamber system mimics situation when catheter 
movement or misplacement causes the shunt to be posi-
tioned with a proportion of holes residing within brain 
parenchyma. The long-chambered system (6-cm cham-
ber length, 5.2-cm catheter length) was designed so all 
holes were at least 1  mm from the alginate gel (Fig. 1b, 
d). This mimics optimal shunt placement with all holes in 
the ventricular space.
A subset of experiments was performed with fluid 
flow to mimic physiologic flow of CSF in vivo [21]. These 
experiments used long-chambered systems and a three-
channel peristaltic pump (Watson-Marlow 401U/DM3, 
Cornwall, UK), similarly to previously described meth-
ods [14]. In brief, media was pumped into the chamber, 
and upon chamber filling, media flowed from outside the 
Fig. 2 Scaffold construction: schematic of the system modeling the 
behavior of reactive cellular responses of astrocytes migrating from 
the parenchyma out to the shunt catheter. Astrocytes were injected 
into an alginate gel scaffold built around the distal portion of a 
clinical grade ventricular catheter. Scaffold preparation begins with 
securing a restraining polystyrene dam around the ventricular por-
tion of the shunt catheter (a). The dam is sealed using low-melting 
point agarose (b). Alginate and crosslinkers are injected into the 
space around the catheter (c) and cured for 30 min (d). The scaffolds 
are then injected with a cell suspension resulting in a density of 
astrocytes similar to that observed in rat cortical tissue (e). The dam is 
removed (f) and incubation begins permitting cell migration through 
the scaffold and onto the catheter
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catheter in through the catheter holes, similarly to CSF 
flow from the outside to the inside of the catheter in the 
ventricles (see Fig. 1d). Media only escaped the chamber 
by traveling through the catheter holes and inside the 
catheter. Briefly, flow rate (0.25  mL/min) and pulsation 
frequency (100 pulses/min) were set using pump speci-
fications and 0.38-mm inner diameter double manifold 
peristaltic tubing (Watson-Marlow). The pump was posi-
tioned outside the incubator and attached to the assem-
bled 3D culture system (chamber, pump, and medium 
reservoir) with barium-free medical grade silastic tubing 
(Advanced Medical Systems, UK). The tubing was steri-
lized with chambers using ethylene oxide. Prior to final 
assembly the tubing was primed with culture media.
Gel characterization
Elastography
The viscoelasticity of alginate hydrogel, without cells, was 
determined using shear wave imaging, where the velocity 
of the wave through the gel is dependent on tissue elas-
ticity [22]. A 200–400 Hz shear wave was launched with 
two consecutive ultrasound images through a 4  % agar 
48  kPa gel with and without the inclusion of a 10  mm 
× 10  mm × 5  mm water-saturated, non-functionalized 
alginate hydrogel. The wave was imaged to determine the 
propagation rate/velocity of the shear wave through the 
gel. The median shear modulus of each sample was indi-
rectly determined from calculations of the speed of the 
waveform through the alginate gels at each pixel. These 
calculations were performed in MATLAB using the 
relationship Ĝ = ρc(ω)2, where Ĝ is the shear modulus, 
ρ is density, c is the group speed of the shear wave, and 
ω is the angular frequency assuming gel incompressibil-
ity. The time of flight algorithm at each pixel was used 
to deduce a shear modulus map through the gel. Three 
median shear modulus measurements were computed 
for a small volume of interest in all alginate gels (n = 3). 
In this way, errors due to gel dimensions and boundary 
conditions were minimized.
Scanning electron microscopy
Pore structure and size was determined in the alginate 
gel using a JEOL Model JSM 7000F (JEOL USE, Peabody, 
MA, USA) scanning electron microscope (SEM) in sec-
ondary electron mode at 10 kV acceleration voltage. Prior 
to being gold sputter coated, samples were washed with 
distilled water to remove salts, frozen in distilled water, 
and lyophilized for 5–7 days.
Fluorescent labeling and spinning disk confocal 
microscopy
Cell viability, cell attachment, and cell growth in the algi-
nate, over the exterior of the catheter, and approximately 
500 µm into the catheter holes, were measured at regu-
lar intervals from every 48  h to once weekly depending 
on experimental conditions and goals. A live/dead assay 
containing 2  µM calcein for live cells (emission/excita-
tion peaks 494/517 nm) and 4 µM ethidium homodimer 
for dead cells (emission/excitation peaks 528/617  nm) 
(Invitrogen) was used to characterize cell growth and 
survival. Confirmation of cell distribution, numbers, and 
morphology was performed after fixation and labeling at 
either short (2-week) or long (8-week) exposures. Sam-
ples were fixed by adding 3–5  mL 4  % (w/v) paraform-
aldehyde to each chamber and incubated for 20  min. 
Using a dissecting microscope at 5×, catheters were 
cut longitudinally to measure astrocyte attachment in 
the catheter lumen and the holes oriented towards the 
bottom and top of the chamber. After rapid rinses with 
HEPES-buffered Hanks solution (HBHS), a 30 min incu-
bation in 0.2  % Triton-X-100 (Sigma) in HBHS and a 
30 min Image-iT FX signal-enhancer (Invitrogen) block-
ing step, astrocytes bound to catheters were labeled with 
1:1000 monoclonal rat anti-glial fibrillary acidic protein 
(GFAP, Invitrogen) during incubations for 24 h at room 
temperature. After washing in HBHS, an aliquot of 1:200 
polyclonal goat anti-rat Alexa Fluor 647 conjugated sec-
ondary antibody (Invitrogen) was applied and incubated 
for 24  h at room temperature. All catheters were addi-
tionally stained with 1:1000 CyQuant (Invitrogen) using 
24 h incubations to identify cell nuclei. An Olympus IX81 
inverted microscope with a DSU spinning disk confocal 
system, motorized xyz stage (American Scientific Instru-
ments, Eugene, OR, USA), and Rolera EM-C2 camera 
(QImaging, Surrey, Canada) was used to acquire 800-µm 
× 800-µm × 500-µm confocal images using a 10× objec-
tive over 200 optical sections with a 2.4  µm step size. 
Datasets were collected in and around each catheter hole 
and on representative surfaces. To visualize the 3D data-
sets, maximum intensity projects were created (Meta-
Morph, Sunnyvale, CA, USA). Holes were referenced one 
through eight as they progressed from the catheter tip 
to alginate scaffold, with the hole closest to the catheter 
tip as hole one (Fig. 1). Data collection for holes one and 
eight was unobtainable due to silicone glue used to fix the 
catheter in the mounting chamber used for microscopy. 
This could not be avoided without risking migration of 
the catheter tip out of the microscope’s focal range.
Cell quantification
The FARSIGHT toolkit (http://www.farsight-toolkit.org) 
was used to segment the fluorescent signal based on seed 
point detection [23–28]. In live-cell imaging, where the 
use of space filling dyes prevented us from separating 
overlapping cells, semi-quantitative results were achiev-
able using volume rendering of the signal intensity.
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Using images acquired with live/dead cell labeling, 
cells were observed to have several characteristic mor-
phologies and organizations—round (small) cells likely in 
a state of movement or mitosis, cell clusters, large cells 
adherent to surfaces, cells lining the catheter hole walls, 
sheets of cells, and cells spanning across holes. A binary 
(yes/no) determination around each shunt catheter hole 
was used to identify an absence or presence of round 
cells, cell clusters, large cells, cells lining the catheter hole 
walls, cell sheets, and cells masses spanning across each 
hole (n =  24). Data around each hole were averaged to 
develop a semi-quantitative scoring system to analyze 
each shunt in each chamber (n = 4). Data are presented 
as the percent of experimental samples (shunts) observed 
with each morphologic characteristic, keeping in mind 
that the percentages are not mutually exclusive.
Post-hoc data was processed by quantifying the num-
ber of CyQuant-labelled cell nuclei using the FARSIGHT 
toolkit. Segmentation algorithms were used to segment 
all cell nuclei. These results were validated by visual 
inspection. Vaa3D Image Visualization and Analysis Sys-
tem was used as an additional quantitative tool to visual-
ize samples in three-dimensional space [29].
Statistical analyses
Statistical analyses were performed using SPSS (IBM 
Corporation; Armonk, NY, USA). The Anderson–Darling 
test for normality was used to divide data into paramet-
ric or non-parametric groups. Parametric data were ana-
lyzed using a paired two-tailed t test, a one-way analysis 
of variance (ANOVA), or a multivariate/repeat measures 
ANOVA with a Bonferroni correction. For all tests, a 
confidence interval was set at 0.95 (α = 0.05). Correlation 
between factors was determined by finding the Pearson 
correlation coefficient. In all repeat measures analyses, 
the Greenhouse-Geisser correction was used following a 
measure of sphericity. Following cases in which a paired 
t test or ANOVA was used, a post hoc Scheffe test was 
performed when the null hypothesis (no difference in 
the group means) was rejected. Non-parametric data 
were analyzed using the Kruskal–Wallis H test with an 
unplanned comparison of mean rank. To compare cat-
egorical data over time, data was preprocessed using 
MATLAB’s trapz function to find the approximate area 
under time-cell attachment curves. The resulting area 
under each curve was used for statistical analysis.
Results
Gel characterization
Two distinct observations were made to characterize 
alginate hydrogel scaffolds as the “brain” portion of the 
3D cell culture system. First, the mechanical integrity of 
alginate scaffolds was measured to compare the modu-
lus of our constructs with that reported for human brain 
parenchyma. The average median shear modulus was 
4.54  ±  0.55  kPa (n  =  5), where the standard deviation 
represents the spatial heterogeneity across all samples 
(Fig. 3). The standard deviation within each gel, whether 
built in the long or short-chambered system, averaged 
0.09 kPa, suggesting that variability observed across gels 
was caused by inconsistencies in different scaffold con-
structs rather than in shear wave imaging. Assuming the 
shear modulus is approximately one-third the Young’s or 
elastic modulus (with near zero Poisson’s ratio), the tested 
alginate gels have an average calculated median Young’s 
modulus of 12.26 kPa. Secondly, SEM was used to assess 
the alginate hydrogel structure, particularly pore size and 
structure, to determine if these measurements were con-
sistent with cell attachment and migration through the 
hydrogel to the catheter surfaces. Pores appeared conical 
with smooth surfaces. The narrower pore openings had 
an average diameter of 296.2 ± 83.8 µm (n = 5, Fig. 4). 
Fig. 3 Scaffold mechanical integrity measured using ultrasound. Representative ultrasound images of an alginate scaffold imbedded in agar. a A 
raw ultrasound image illustrating an alginate scaffold embedded in agar. b A shear modulus map from a portion of the raw ultrasound image. c A 
shear modulus map of alginate scaffold after removing signal contributed by the agar embedding medium. These shear measurements were used 
to calculate the average median Young’s modulus. Measurements and calculations were made as described in the “Methods”
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The smooth pore surfaces and relative large open pores 
are consistent with a structure that allows cell growth 
and movement.
Astrocyte morphological characteristics and viability 
over time using the short‑chambered design
Representative images of each classified morphological 
characteristic can be found in Fig. 5. It was clear that, over 
time, astrocytes emerged from the scaffold and attached 
to the outside of the catheter. Round cells were observed 
throughout 23  days of incubation and were observed 
in the alginate scaffold as well as on catheters where 
they were primarily observed near or in holes. We have 
defined ‘large cells’ (average diameter 19.17 ±  4.96  µm) 
as those in excess of 180 % the size of the typical astro-
cytes observed (average diameter 10.65 ± 2.76 µm). The 
number of large adherent cells generally increased over 
time. At longer culture times (>44  days of incubation) 
these hypertrophied astrocytes had a more cylindrical 
morphology and decreased in number. The large adher-
ent cells were observed almost exclusively bound flat 
onto the shunt surface, whereas rounder/smaller astro-
cytes (average diameter 7.33 ±  2.09 µm) were observed 
in the shunt holes and in the alginate gel. Cells were also 
observed as clusters or sheets containing ten or more 
cells with interconnected processes. These were most fre-
quently observed as clusters in the alginate scaffold or as 
sheets or clusters across or in catheter holes.
Pearson correlation coefficient’s defined the association 
between morphological characteristics, independent of 
time, where positive correlations existed between large 
cells, cells lining the catheter hole wall, cells stretching 
across the hole, and cell sheets. Pairwise comparisons of 
astrocyte morphology over time in the short-chambered 
systems were performed using multivariate/repeat meas-
ures ANOVA (Table 1). Cell clusters and round cells were 
inversely related to these categories. The number of large 
cells increased with time in culture, reaching statistical 
significance (P < 0.05) from 2 days to all other time points 
and between days 16 and 37. A similar phenomenon was 
seen with cells lining the catheter holes as well as tissue 
spanning the catheter holes until day 44 when sudden 
decreases were observed (Figs. 6, 7). The number of cells 
lining the hole walls at each time point increased signif-
icantly (P  <  0.05) compared to data at 2  days, and then 
thereafter from nine to 16 and to 23 days. Cells clustered 
more outside the gel on the shunt catheter than inside 
the gel at days 37, 44, and 51 (Fig. 7a, c). The average vol-
ume of fluorescently-intense live cell signal, indicative of 
the volume of living cells in the short-chambered system, 
was generally cyclical, where total cell volumes growth 
decreased at day 16 and 44 on the shunt hole inside or 
outside the scaffold (Fig. 7b, d). The degree of cell growth 
across holes was significantly greatest at day 37, but the 
ratio of living to dead cells fluctuated over time with the 
largest decrease in viable cells at 44 days when the pres-
ence of cells across holes trended downward.
To confirm our findings that cell attachment generally 
increased over time, we quantified the number of cells 
attached to the shunt catheter at varying fixed end points 
(14 and 56 days). Similarly to analysis of viable cells over 
time, a significant (P  <  0.001) difference in total cell 
attachment and growth was observed between experi-
mental endpoints 14 and 56 days (2 and 8 weeks, Fig. 8).
End point analysis of cell attachment on varying shunt 
surfaces
Using the short-chambered system at fixed endpoints (14 
and 56  days in culture), we compared astrocyte attach-
ment and growth at varying locations within the system 
(i.e. on the shunt catheter in and out of the gel, on the 
catheter’s top and bottom halves, and in shunt catheter 
holes and on shunt catheter surfaces between holes). 
There was a significant increase in cell attachment in 
and around the catheter holes and on shunt surfaces 
(between holes) from 14 to 56 days (P < 0.001 and <0.01, 
respectively). By 56  days (8  weeks), significantly more 
cells were attached to holes than to catheter surfaces 
(P < 0.05). There were no significant differences between 
the numbers of cells on the top and bottom portions of 
catheters (gravity-dependent variation). There were also 
no significant differences in cell attachment inside versus 
outside of the gel, but cell numbers trended upward clos-
est to the gel.
Fig. 4 Alginate scaffold pore structure. Scanning electron micros-
copy image illustrating the pore structure of the alginate scaffolds. 
Sheets of alginate form cone-shaped pores. The narrowest diameters 
of these pores averaged 296.2 ± 83.8 µm (n = 5)
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Effect of shunt position: variance between short‑ 
and longchambered design
Total cell attachment on shunt catheters was depend-
ent on the initial positioning of the shunt in reference 
to the gel. That is, data collected using the short-cham-
bered design, where half of the shunt’s ventricular cath-
eter holes were covered by the gel, had significantly less 
total shunt-cell binding per square millimeter than data 
collected using the long-chamber design, where none of 
the shunt’s ventricular catheter holes were initially cov-
ered by the gel (P < 0.001). The key variance in total cell 
attachment appeared at hole 5, where there was signifi-
cantly more cell attachment on shunts in the long-cham-
bered design than on shunts in the short-chambered 
design (P < 0.05, data not shown). Differences in attach-
ment at all other holes were insignificant.
Flow dependent attachment and growth using the 
long‑chambered design
A subset of long-chambered units (n  =  3) were used 
to observe the effects of flow-induced shear at physi-
ologic flow rates on cell attachment and growth. After 
exposure to peristaltic flow for 18  h, there was a quali-
tative decrease in the total number of attached cells, 
but this difference was not significant compared to the 
degree of attachment before flow (P  =  0.086, Fig.  9a). 
When exposure to flow was analyzed with respect to 
hole location, there was a significant difference due to the 
effect of flow and added exposure time (18 h) at hole four 
(P < 0.01, Fig. 9b).
Discussion
The complex mechanisms of shunt obstruction are multi-
faceted and poorly understood requiring systematic study 
with single variable manipulation, in order to appreciate 
how and why shunt failure occurs. Data presented here 
demonstrate that astrocytes may preferentially attach 
to the walls of the catheter holes resulting in accumula-
tions of additional cells. Cell accumulation can result in 
cell sheets or cell masses completely occluding the cath-
eter holes (Figs.  5, 6). We propose that shunts fail after 
becoming obstructed with attaching glial cells, creating a 
substrate for more glia or other cells and tissues (e.g. cho-
roid plexus) to secondarily bind to the shunt and block 
Fig. 5 Representative 3D confocal imaging stacks displaying astrocyte morphological characteristics. Round, small cells likely in a state of move-
ment or mitosis (A, black arrowhead) cluster together as if they were locally synchronized (B, arrow). Cells larger than the small, round cells of A, with 
more extended processes (C, white arrow) are likely adhered to the catheter surface. C–F Cells forming a network have been denoted as sheets of 
cells. Cells lining the walls of the shunt catheter holes (C, D, F, black arrow) seem to appear prior to cell masses crossing the hole to the opposite 
wall (E, F, white arrow). Scale bar represents 100 µm
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CSF flow. Our in vitro system models this inflammatory 
response by replicating the interface between the paren-
chyma and shunt using an astrocyte-seeded 3D alginate 
scaffold surrounding a portion of the shunt’s ventricular 
catheter.
Physical properties of the 3D alginate matrix modeling the 
parenchyma
Alginate, a natural polysaccharide used extensively as 
a hydrogel synthetic extracellular matrix (ECM), has 
numerous free functional groups to enable inclusion 
of biochemical signaling molecules, like the tripeptide 
RGD [15]. Unlike other scaffold materials, alginate does 
not require the addition of cytotoxic agents to crosslink. 
In this study, an alginate matrix was seeded with astro-
cytes at a high density to mimic the astrocyte density 
in human cerebral cortex. The hydrogel held cells in 3D 
space while providing adequate space for cell attachment, 
proliferation, cell movement, and normal cell metabolic 
function. Using our protocol, the alginate gel had a simi-
lar pore macrostructure to 5.0 % (w/v) gelatin foam made 
to mimic ECM, but lacked the collagen-like nanofibrous 
architecture which may contribute to cell attachment 
and growth [30]. The relatively large pore size of the algi-
nate matrix was sufficient to allow astrocytes to extend 
their processes and to maintain cell clusters within an 
Table 1 Statistically significant pairwise comparisons 
of  astrocyte morphology over  time (P < 0.05) using 
multivariate/repeat measures ANOVA with  Bonferroni 
and Greenhouse-Geisser corrections
Time Category Category
2 days Large cells Cell clusters
Round cells
Cells lining hole wall Cell clusters
Round cells




Cell sheet Cell clusters
Round cells
Cell clusters Large cells
Cells lining hole wall
Tissue spanning across hole wall
Cell sheet
Round cells
Round cells Large cells
Cells lining hole wall
Tissue spanning across hole wall
Cell sheet
Cell clusters




Cells lining hole wall Tissue spanning across hole wall
Cell clusters
Round cells





Cell sheet Cell clusters
Round cells
Cell clusters Large cells
Cells lining hole wall
Tissue spanning across hole wall
Cell sheet
Round cells
Round cells Large cells
Cells lining hole wall
Tissue spanning across hole wall
cell sheet
Cell clusters
16 days Large cells Round cells
Cells lining hole wall Tissue spanning across hole wall
Round cells
Tissue spanning across hole 
wall





Cell sheet Cell clusters
Round cells
Cell clusters Tissue spanning across hole wall
Cell sheet
Round Cells
Round cells Large cells
Cells lining hole wall
Tissue spanning across hole wall
Cell sheet
Cell clusters
23 days Large cells Round cells
Cells lining hole wall Round cells
Tissue spanning across hole 
wall
Round cells
Cell sheet Round cells
Cell clusters Round cells
Round cells Large cells
Cells lining hole wall
Tissue spanning across hole wall
Cell sheet
Cell clusters
Based on estimated marginal means
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individual pore (Fig. 4). Although the morphology of the 
cells pointed to near-normal cell function, the rate of cell 
migration onto the shunt surface was not directly compa-
rable to in vivo preparations. Future work should include 
a thermally-induced phase separation technique and/or 
porogen leaching to create a nanofibrous structure with 
interconnected macroporous architecture to more accu-
rately mimic cortical tissue. The addition of proteogly-
cans may also more accurately mimic in vivo conditions 
[31, 32].
Tissue/gel elasticity plays an important role in ECM 
assembly, cell spreading, and cell motility; therefore, 
our model should include a gel with similar elasticity to 
tissue. Anchorage-dependent cells, like astrocytes, are 
particularly responsive to the mechanical properties of 
their matrix, and preferentially attach to stiffer surfaces 
[33]. The stiffness of brain tissue varies in the literature, 
probably because of a dependence on acquisition method 
(e.g. acquisition frequency), mathematical assumptions, 
the specific brain region assayed, and the presence of 
Fig. 6 Astrocyte extension and retraction across shunt catheter holes. Representative images of a single catheter hole in the short-chambered 
system taken between 16 and 51 days of culture. The sample was stained to reveal viable (green) and non-viable (red) cells. Viable astrocytes are 
observed in holes as early as 16 days after the perfusion system was initiated. The dynamic growth (and retraction) of cells is illustrated in the 37-, 
44-, and 51-day images when cells were observed bridging across the hole or lining the catheter hole wall. These images are maximum projections 
of 3-D confocal images. Scale bar represents 100 µm
Fig. 7 Astrocyte morphology and viability over time. Morphology (a, c) and viability (b, d) of astrocytes measured over time in a short-chambered 
system. Each row of figures presents data as observations made across the shunt catheter holes encased in the alginate gel (a, b), and holes outside 
of the gel (c, d). Morphology was scored by cell organization (single round cells, cell clusters, large cells, cell sheets and cells spanning shunt cath-
eter holes). Data are presented as the total percent of shunts observed with each morphologic characteristic (n = 4), where the percentages are not 
mutually exclusive. Cell viability is scored by normalized fluorescent signal visualized using a live/dead cytotoxicity assay. The percent of viable cells 
out of the total cells is expressed above each time interval
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any pathology. Young’s moduli of whole brain tissue can 
range from of 0.5–37  kPa, acquired from mathematical 
modeling [34], magnetic resonance elastography (MRE) 
[35, 36], and shear wave imaging [22]. Reported shear 
moduli also varies, ranging anywhere from 2.5 to 15 kPa 
for white matter and 2.8–13 kPa for gray [37]. Comparing 
data acquired from shear wave imaging only, we see that 
our gel (measured shear modulus 4.54 ± 0.55 kPa, calcu-
lated Young’s modulus 12.26  kPa) falls within this large 
range, but is less stiff than Mace et al’s shear wave meas-
ured shear moduli of whole brain (12.3 ± 0.7 kPa) and of 
cortical tissue (12.9 ± 1.3 kPa) [22].
We chose to maintain these mechanical properties for 
two reasons. First, the measured shear modulus does fall 
within the wide range of reported shear moduli. Second, 
recent evidence indicates that brain parenchyma modu-
lus in hydrocephalic patients may be considerably lower 
than originally predicted, and lower than non-pathologic 
brain parenchyma due to pathological factors that influ-
ence brain compliance including tissue compression 
against the rigid skull, and the chronic white matter dam-
age associated with hydrocephalus [34]. The high stiffness 
of the shunt catheter relative to brain parenchyma may 
contribute to cell migration and/or proliferation on the 
catheter surface. Over time, the cell population on the 
catheter surface increases, as does the number of cells in 
the catheter hole wall where surface roughness is higher 
[38]. In preliminary results in our lab using the same algi-
nate preparation but with cells mixed into the gel rather 
than injected, the shear modulus (11.68  ±  2.78  kPa) is 
similar to the shear modulus of whole brain and cortical 
tissue. Future work will closely examine this relationship 
in an effort to improve our relevance to in vivo hydroce-
phalic conditions.
Finally, it is important to note that Ca2+ cross-linked 
alginate hydrogels lose mechanical properties over time 
in  vitro, presumably due to slow loss of crosslinking 
Ca2+ ions into the culture medium [16, 39]. This loss of 
scaffold integrity may have contributed to the observed 
increase in cell death after 23 days post-seeding (see cell 
quantification discussion below).
Cellular properties of the 3D alginate matrix
The morphology and organization of cells was as 
expected, where some astrocytes were found adherent 
to the shunt catheter surface (‘large’ cells), and others 
(‘round’ cells) were imaged as they were likely navigat-
ing toward a point of attachment on the gel or catheter 
(Fig. 7). Differences in morphological characteristics were 
more pronounced in the first 16 days of experimentation, 
indicative of astrocyte activity and/or a sustained evoked 
inflammatory response to the alginate gel or the shunt 
catheter. Interestingly, the number of adherent ‘large’ 
cells appears to wax and wane over time in a cyclical pro-
gression toward shunt catheter obstruction. The gradual 
increase, sharp decrease, and subsequent increase in 
viable cells observed from day 37 to 51 in our chronic 
experiments, while initially counterintuitive, may yield 
new insight into shunt obstruction at the sight of the ven-
tricular catheter. Initially (48 h to 37 days post seeding), 
the average volume of space occupied by viable cells, the 
presence of cells lining the hole walls, the presence of a 
sheet of cells, and the presence of cell growth across holes 
generally increases regardless of catheter hole location 
Fig. 8 Acute and chronic astrocyte attachment on/around shunt catheter holes and surfaces. Number of astrocytes attached to the shunt catheter 
surface in the short-chambered system using post hoc cell nuclei counting at 2- and 8-week incubations. (*P < 0.05, **P < 0.01, ***P < 0.001). Sur-
face area was not accounted for in these estimates (see “Discussion”)
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(in or out of the gel), probably due to cell proliferation, 
cell spreading, and cell migration. After 44  days in cul-
ture, the volume of viable cells decreases, the volume of 
non-viable cells dramatically increases, the presence of 
cells lining the catheter holes decreases, and the presence 
of tissue across the holes decreases. That is, the viable 
cell masses appear to retract instead of spread, possibly 
because of chemical cues (contact inhibition, internal 
tension, a lack of available ECM, a change in cell shape) 
or physical cues (distance between adhesive hole walls). 
Then, after 51 days in culture, this retraction is overcome 
and viable cell attachment returns. This is coupled with a 
reduction in round cells and an increase in cells lining the 
hole walls, cell sheets, and tissue across holes. This cyclic 
pattern of progression was seen repetitively across sam-
ples, but we must acknowledge that some experimental 
caveats, like the static environment, number of media 
changes, and lack of other cell types could contribute to 
these findings. If this finding is physiological, however, 
this phenomenon may begin to depict how shunt catheter 
obstruction by astrocytes occurs. We can speculate that 
perhaps the rate of this cyclical cell viability is different 
across patients, explaining, in part, why shunt obstruc-
tion occurs at different rates in patients despite similar 
Fig. 9 Introduction of physiologic fluid flow. Total (a) and per hole (b) cell attachment under static conditions and under physiological flow after 
18 h in the long-chambered system. A trend in the data show a reduction in total cell attachment under conditions of flow and at each hole 
(*P < 0.05)
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cell types found obstructing shunt catheters. Impeding 
the rate of cell spreading by disrupting the receptor-
ligand interactions or by enhancing retraction through 
chemical or physical means may be potential methods 
to reduce the rate of shunt obstruction. Work comparing 
this model to catheters explanted from patients is ongo-
ing in our lab and will help validate potential mechanisms 
underlying cell-catheter interactions.
Post-hoc analysis of the luminal surface of the catheters 
confirmed the live/dead assay data, with cell attachment 
and growth generally increasing over time, with signifi-
cantly more astrocytes bound to shunts incubated for 
8  weeks compared to 2  weeks, regardless of using the 
short- or long-chambered systems (Fig. 8). After 8 weeks, 
astrocytes bound preferentially to shunt catheter holes 
as compared to shunt catheter surfaces, perhaps because 
of greater surface roughness of the hole walls [40–43]. 
However, our cell attachment data were collected by ana-
lyzing confocal stacks of the same x,y space capturing all 
attached cells in z-space. Through the holes, the surface 
area for cell binding was at least two times greater than 
the surface area of the same x,y space on the shunt sur-
face because of the hole’s z height. Accounting for this 
difference minimizes any preferential binding on the 
shunt holes to near zero. If we assume that attachment on 
the shunt hole walls leads to an extension of tissue across 
the hole, flow would impeded throughout the hole, inde-
pendent of where the cell mass was in z-space. So, this 
surface area normalization may not be clinically relevant.
Interestingly, there appeared to be more cell attachment 
in our long-chambered design than our short-chambered 
design where holes were in the gel modeling the brain 
parenchyma. This is counter-intuitive, since suboptimal 
shunt placement or shunt movement has been shown 
to increase failure rates. This may be because the long-
chambered design contained a larger volume of nutrient-
rich cell culture media than the short-chambered design. 
Fortunately, introducing flow into the model eliminated 
any issues of cell starvation and improved the physiologi-
cal relevance of the system.
Flow‑dependent cell attachment
There are very few models that try to interpret the effects 
of flow on cell attachment to improve hydrocephalus 
treatment. Astrocytes are an appropriate cell type to ana-
lyze flow-dependent changes in attachment because flow 
has been shown to dramatically influence the degree of 
attachment, and to a lesser extent astrocyte morphol-
ogy [14]. In our previous model, the hydrocephalus 
shunt catheter bioreactor (HSCB), we showed that sus-
pended astrocytes have an increased binding propensity 
with increasing flow-induced shear stress (shear stress 
from 0.0039 to 0.0134 Newton per square meter, N/m2), 
presumably because of (1) a rate-dependent change in 
the cell receptor to bound protein ligand contact time 
and contact incidence; and/or (2) a biochemical change 
in astrocyte properties [14]. This finding was threshold 
dependent, however, and a relatively large shear stress 
(0.2409 N/m2) generated enough force to overcome any 
cell-protein interactions generated from flow [44]. In 
the present study, increasing shear stress at low levels 
by introducing physiological flow (0.0089 N/m2 through 
the catheter lumen, 0.0075  N/m2 through each catheter 
hole assuming that flow is dispersed equally through 
each hole) appears to decrease attachment after approxi-
mately the same time period (18 h)—perhaps because an 
increase in flow disrupts contact between the attached 
cells and the adsorbed protein ligands (Fig.  9). Parsing 
the data into cell attachment around each hole, we can 
see that hole five appears to have the most cell attach-
ment in both the static and fluidic long-chambered sys-
tems. Because results are similar to the static cultures 
and because we know that flow is not evenly distributed 
across the holes [45], we can predict that attachment is 
not directly associated with calculated flow-induced 
shear in this model.
The HSCB model and the flow model in the present 
study, model quite different mechanisms of ventricu-
lar catheter obstruction: the former measures how flow 
modulates the act of single-cell attachment, whereas 
the latter measures how physiologic flow disrupts cells 
already attached to the catheter and migrating down the 
catheter shank. Both of these mechanisms are quite rel-
evant to shunt obstruction; we must prevent both. Future 
work must include analysis of the chronic effects of flow, 
and should also examine how flow modulates the act of 
whole-tissue (e.g. choroid plexus) attachment without 
static incubation preceding flow. It is necessary to delin-
eate the difference between cell attachment and growth 
because flow, surface chemistry, and the architecture of 
the catheter may influence these factors independently, 
as has been shown [10, 38, 46, 47]. Future studies should 
include detachment experiments to record the initial 
strength of cell adhesion, cellular morphological assess-
ment, and quantification of proliferation over time [48]. 
This model can be modified to incorporate other cells 
in the 3D scaffold, like microglia, blood-borne mac-
rophages, and necrotic cellular debris and by combining 
with a previous model using cells suspended in a CSF-
like solution, like astrocytes [14], microglia, bacteria, 
red blood cells or platelets, tumor cells, or necrotic cel-
lular debris. Ongoing studies in our lab are experiment-
ing with the incorporation of rat choroid plexus explants 
and ependyma. Finally, we can examine the role of these 
cells, cell masses, and tissues on shunt valve obstruction 
by using clinical hardware in vitro.
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It has been shown that irritation and inflammation 
of periventricular tissue is a source for reactive cells to 
infiltrate the catheter [10, 11, 13, 49, 50]. The irritation 
of the parenchyma and the resulting astrocytic response 
is modeled here. Our model can also incorporate impor-
tant pathophysiologic changes such as fluctuations in 
intracranial pressure or protein concentration both in 
the gel (modeling the parenchyma) and in the solution 
(modeling CSF). Other cell types can also be introduced 
by themselves or as a co-culture with astrocytes. Cho-
roid plexus infiltration causing shunt failure has not been 
addressed in this model, but serves as an area of future 
work for our lab. The development of cerebral organoids, 
which could potentially recapitulate choroid plexus may 
be an avenue worth exploring in this endeavor [51]. An 
extensive analysis of resected catheters from patients 
provides supporting observations that the growth of 
cells in our 3D culture system closely mimics what we 
observe on resected catheters and supports our proposal 
that astrocytes and microglia migrating from the brain 
parenchyma may be predominately responsible for cell 
obstruction of catheter holes.
Conclusions
Alone or in combination with previously-published cell 
culture models of shunt obstruction, this model serves 
as a relevant test bed to analyze mechanisms of shunt 
failure and test catheter modifications that will prevent 
cell attachment and growth. Of particular relevance, 
we found that: (1) the stiffness of the three-dimensional 
cell-loaded “parenchyma” falls in a similar range to 
brain; (2) astrocytes are viable and migrate out of the gel 
similarly to how cells are hypothesized to migrate from 
brain parenchyma; (3) astrocyte attachment around 
shunt catheter holes appears to extend and retract across 
the hole in a cyclical pattern of attachment leading to 
obstruction; (4) the three-dimensional scaffold system 
can be incorporated into a fluidic cell culture system to 
mimic some physiologic parameters seen in the brain’s 
ventricular space.
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